Announcements Trials
Browse Landscape

Status

Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 2Neoplasm, Residual 1NSCLC 1Liver Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 6fludarabine phosphate 5Busulfan 5Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Imatinib Mesylate 4Hydroxyurea 4Cytarabine 4Antilymphocyte Serum 4Radiotherapy 3Melphalan 3Interferon-alpha 3Dasatinib 3olverembatinib 2Tacrolimus 2Polymerase Chain Reaction 2Methylprednisolone 2Idarubicin 2Filgrastim 2Cyclosporine 2Cord Blood Stem Cell Transplantation 2sargramostim 1nilotinib 1inecalcitol 1flumatinib 1danusertib 1avelumab 1Whole-Body Irradiation 1Tyrosine Kinase Inhibitors 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Myeloid, Chronic-Phase × Tyrosine Kinase Inhibitors × Clear all
NCT06121765 2023-11-08

Metabolic Alternation and Clinicohematological Characteristic in Chronic Phase CML in Patient Treated With TKI

Assiut University

Unknown
45 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡